Univ Health Svc Stock Price, News & Analysis

Universal Health Services (NYSE: UHS) has declared a quarterly cash dividend of $0.20 per share, payable on December 17, 2024, to shareholders of record as of December 3, 2024. UHS operates as one of the nation's largest healthcare providers, managing acute care hospitals, behavioral health facilities, and outpatient services across the United States, Puerto Rico, and the United Kingdom.

Universal Health Services (NYSE: UHS) has announced its participation in the 2024 Wolfe Research Healthcare Conference in New York. Executive Vice President and CFO Steve Filton will deliver a presentation on Tuesday, November 19, 2024, at 12:20PM ET.

The presentation will be accessible through a live audio webcast on the company's website (www.uhsinc.com), with replay availability for 90 days post-conference. UHS operates acute care hospitals, behavioral health facilities, and ambulatory centers across the United States, United Kingdom, and Puerto Rico, positioning it as one of the nation's largest hospital companies.

Universal Health Services (UHS) reported strong financial results for Q3 2024. Net income reached $258.7 million ($3.80 per diluted share), up from $167.0 million in Q3 2023. Net revenues increased 11.2% to $3.963 billion. The company's acute care facilities saw adjusted admissions increase by 1.5%, while behavioral health facilities experienced a 2.2% rise. EBITDA margin improved to 13.3% from 11.5% year-over-year. UHS completed a $1 billion financing transaction and authorized a $1.0 billion increase to its stock repurchase program, under which it repurchased 658,000 shares for $153.9 million in Q3.

United Health Services (UHS), a major healthcare system in Upstate New York, has launched a focused ultrasound program to treat essential tremor. This incisionless and minimally invasive treatment uses MRI-guided ultrasound energy to target the brain area causing tremor. UHS is the first and only healthcare system in Upstate New York offering this state-of-the-art technology.

Essential tremor, affecting an estimated 10 million Americans, can significantly impact quality of life. The focused ultrasound treatment has shown an average of 73.1% improvement in hand tremor severity at 5-year follow-up. As an outpatient procedure, it allows for quick recovery with patients returning home the same day.

UHS is now scheduling appointments to screen individuals for essential tremor and discuss treatment options. Patients can contact UHS at tremortreatment@nyuhs.org or 607-763-5404 for more information.

Universal Health Services (NYSE: UHS) has announced the date for its third quarter 2024 earnings release and conference call. The company will report results for the quarter ended September 30, 2024, after market close on Thursday, October 24, 2024. A conference call for investors and analysts is scheduled for 9:00 a.m. Eastern Time on Friday, October 25, 2024.

Interested parties can access a live webcast of the call on the company's website at www.uhs.com. To participate via telephone, registration is required in advance through a provided link. Upon registration, participants will receive confirmation details including dial-in information and unique access codes. A replay of the call will be available for one full year following the live call.

Universal Health Services (NYSE: UHS) has announced the pricing of its public offering of senior secured notes. The company is offering $500 million of 4.625% notes due 2029 and $500 million of 5.050% notes due 2034. These notes will pay interest semi-annually and be secured by first-priority liens on certain company assets. The offering is expected to close on September 26, 2024.

UHS intends to use the net proceeds to repay outstanding amounts on its current tranche A term loan facility. The offering is being made through an effective shelf registration statement with the SEC, and is only available through a prospectus supplement and accompanying prospectus.

Universal Health Services (NYSE: UHS) has announced its intention to offer senior secured notes, subject to market conditions. The exact terms, including maturity, interest rate, and principal amount, will be determined at pricing. The net proceeds from this offering will be used to repay certain amounts outstanding under the company's current tranche A term loan facility.

The offering is being made through an effective shelf registration statement filed with the SEC. Interested parties can obtain the preliminary prospectus supplement and accompanying prospectus from various financial institutions, including J.P. Morgan Securities, BofA Securities, Truist Securities, U.S. Bancorp Investments, and Wells Fargo Securities.

Universal Health Services (UHS), a leading provider of hospital and healthcare services, has announced its participation in two major healthcare conferences in September 2024. Steve Filton, Executive Vice President and CFO, will represent UHS at these events:

1. The 2024 Wells Fargo Healthcare Conference in Boston on September 6 at 9:30am (ET)
2. The Baird 2024 Global Healthcare Conference in New York on September 11 at 9:05am (ET)

Both presentations will be live-streamed on the UHS website (www.uhs.com), with replays available for 90 days after the events. UHS operates acute care hospitals, behavioral health facilities, and outpatient services across the United States, Puerto Rico, and the United Kingdom.

Universal Health Services (NYSE: UHS) reported strong Q2 2024 financial results, with net income rising to $289.2 million ($4.26 per diluted share) compared to $171.3 million in Q2 2023. Net revenues increased by 10.1% to $3.908 billion. The company's adjusted net income was $292.6 million ($4.31 per diluted share), up from $179.4 million in Q2 2023. UHS also announced a $1 billion increase to its stock repurchase program authorization.

Based on strong performance, UHS increased its 2024 full-year forecast. Revised projections include net revenues of $15.565-$15.753 billion, adjusted EBITDA of $2.154-$2.226 billion, and adjusted EPS of $15.40-$16.20 per share. These figures represent significant increases from the original forecast, reflecting the company's positive outlook.